NCT04440215: Telestroke

Optimizing Patient Adherence to Stroke Rehabilitation Treatment

Status unknown NA Last updated 21 July 2021

What this trial tests

NA trial testing Telerehabilitation and team meetings and team care plans in Stroke Rehabilitation in 330 participants. Status unknown.

Timeline

10 July 2020

Primary endpoint
1 December 2023

1 December 2024

Quick facts

Lead sponsor	Université de Sherbrooke
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	sequential
Masking	none
Primary purpose	health services research
Enrollment	330
Start date	10 July 2020
Primary completion	1 December 2023
Estimated completion	1 December 2024
Sites	6 locations across Canada

Drugs / interventions tested

• Telerehabilitation and team meetings and team care plans
• Usual care

Conditions studied

• Stroke Rehabilitation — all drugs for Stroke Rehabilitation →
• Telerehabilitation — all drugs for Telerehabilitation →
• Decision Making, Shared — all drugs for Decision Making, Shared →

Sponsor

Université de Sherbrooke — full company profile →

Who can join

18 and older, any sex, with Stroke Rehabilitation or Telerehabilitation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Stroke impacts nearly 400,000 Canadians annually. Three quarters of stroke survivors will live with minor to severe impairments or disabilities; which require rehabilitation care. Strong evidence supports beginning rehabilitation as soon as the patient's medical status has stabilized and continuing following discharge from acute care. Access to optimal services is hampered, however, by travel distances to access rehabilitation, the lack of opportunities for structured and formal interprofessional communication among service providers, and failures to engage the patient and family members in a structured decision making process. Moreover, adherence to rehabilitation treatments has been shown to be suboptimal. Many patients refuse their outpatient rehabilitation treatments outright or decrease the duration and/or frequency of their treatments over time.

The aim of this proposed mixed methods pragmatic clinical trial is to evaluate an intervention that provides patients who have experienced stroke the opportunity to return home safely after their acute hospital stay, to encourage patient (and family) engagement in their rehabilitation care, and to overcome challenges of access to patient-centered interprofessional rehabilitation care.

The proposed intervention will entail 220 patients (and family) to receive rehabilitation care through remote, live treatment sessions with an interdisciplinary group of clinicians (called telerehabilitation) versus standard of care (n = 110 patients). Five rehabilitation teams will be trained to develop rehabilitation treatment plans that engage the patient and family, while taking advantage of a telerehabilitation platform to engage the patient/family. Grounded in findings gathered through a Canadian Institute of Health Research (CIHR) funded pilot study, the primary study objective is to evaluate process, clinical outcomes and costs of telerehabilitation in comparison with usual care. Through qualitative interviews with patients and family as well as clinicians, a second objective of this pragmatic, controlled trial is to explore and describe contextual factors (both personal and environmental) that will help the delivery of care, and improve patient's outcomes while fully using technology to deliver stroke rehabilitation care.

This study represents a unique, highly relevant opportunity to minimize both knowledge and practice gaps, while producing robust, indepth data on the factors related to the effectiveness of telerehabilitation.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Effects of Telerehabilitation on Patient Adherence to a Rehabilitation Plan: Protocol for a Mixed Methods Trial.
   Gaboury I, Tousignant M, Corriveau H, Menear M, et al · · 2021 · cited 7× · PMID 34709196 · DOI 10.2196/32134